Irg1 inhibitor
WebAug 20, 2024 · IRG1 catalyzes the production of a TCA derivative, itaconate, an inhibitor of succinate dehydrogenase (SDH). TCA enzyme activities and kinetics were analyzed after miR-144 silencing in obese mice and human liver organoids using single-cell activity assays in situ and molecular dynamic simulations. WebJul 1, 2016 · Itaconate levels and Irg1 expression correlate strongly with succinate during LPS exposure in macrophages and non-immune cells. We demonstrate that itaconate acts as an endogenous succinate dehydrogenase inhibitor to cause succinate accumulation.
Irg1 inhibitor
Did you know?
WebApr 22, 2013 · We purified IRG1 protein and identified its cis -aconitate decarboxylating activity in an enzymatic assay. Itaconic acid is an organic compound that inhibits … WebBy detecting the activation of glucose-6-phosphate dehydrogenase (G6PD), we confirmed that IRG1 could increase ROS level by promoting pentose phosphate pathway (PPP). DPI, …
WebDec 17, 2024 · IRG1 immune-responsive gene 1 KIM-1 kidney injury molecule-1 LDH lactate dehydrogenase mTOR mammalian target of rapamycin NES normalized enrichment score NGAL neutrophil gelatinase-associated lipocalin NLRP3 NOD-, LRR-, and pyrin domain-containing protein 3 PAS periodic acid-schiff PKM2 pyruvate kinase M2 PPARα WebApr 20, 2016 · The interferon-γ (IFN-γ)-inducible immunity-related GTPase (IRG), Irgm1, plays an essential role in restraining activation of the IRG pathogen resistance system. …
WebJul 1, 2024 · To determine if IRG1 is a druggable target in cancer, we synthesized a series of small MW inhibitors and selected ERG344 for in vivo testing based on its ability to inhibit itaconate synthesis in a rat glioblastoma cell line (C6) engineered to stably express Irg1. WebInositol-requiring enzyme 1 (IRE1) is a bifunctional serine/threonine kinase and endoribonuclease that is a major mediator of the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. It represents a potential therapeutic target for a number of diseases associated with endoplasmic reticulum stress.
WebJul 1, 2024 · To determine if IRG1 is a druggable target in cancer, we synthesized a series of small MW inhibitors and selected ERG344 for in vivo testing based on its ability to inhibit …
WebIRG1-IN-1 is an itaconic acid derivative. IRG1-IN-1 can inhibit immune-responsive gene 1 (IRG1) activity. IRG1-IN-1 can be used for the research of cancer, inflammation and … ipg health frankfurtWebApr 10, 2024 · An inflammatory stimulus such as LPS promotes the expression of Irg1, which transforms cis-aconitate to itaconate in the mitochondrial matrix. Itaconate is converted to itaconyl-CoA, and then citramalyl-CoA. Citramalyl-CoA is catalyzed to pyruvate and acetyl-CoA by citrate lyse subunit beta-like (CLYBL). Acetyl-CoA will be reused by the … ipg health networkWebWe found that deletion of immune-responsive gene 1 (IRG1), encoding for the enzyme producing itaconate, exacerbated liver injury and systemic inflammation. ... Under homeostatic conditions, Nrf2 is maintained at a low level in the cytosol as an inactive complex by its inhibitor protein, Kelch-like ECH-associated protein 1 (Keap1), ... ipg health glasgow